Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabineLeore T. Geller, Ravid Straussman, Michal Barzily-Rokni et al.|Science|2017Cited by 1.8k
Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a TaxaneLinda T. Vahdat, Joanne L. Blum, David A. Smith et al.|Journal of Clinical Oncology|2009Cited by 245